Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Payables (2020 - 2026)

SkinHealth Systems has reported Payables over the past 6 years, most recently at $15.6 million for Q4 2025.

  • Quarterly Payables fell 28.76% to $15.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.6 million through Dec 2025, down 28.76% year-over-year, with the annual reading at $15.6 million for FY2025, 28.76% down from the prior year.
  • Payables was $15.6 million for Q4 2025 at SkinHealth Systems, down from $17.3 million in the prior quarter.
  • Over five years, Payables peaked at $44.8 million in Q4 2023 and troughed at $15.6 million in Q4 2025.
  • The 5-year median for Payables is $27.0 million (2022), against an average of $27.5 million.
  • Year-over-year, Payables soared 348994.41% in 2021 and then tumbled 50.99% in 2024.
  • A 5-year view of Payables shows it stood at $29.0 million in 2021, then fell by 2.0% to $28.5 million in 2022, then surged by 57.26% to $44.8 million in 2023, then tumbled by 50.99% to $21.9 million in 2024, then decreased by 28.76% to $15.6 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Payables are $15.6 million (Q4 2025), $17.3 million (Q3 2025), and $23.0 million (Q2 2025).